Prevalence of Bacteriuria, Antibiotic Susceptibility, and Treatment Response in Symptomatic Benign Prostatic Hyperplasia
NCT06520267 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 131
Last updated 2024-07-25
Summary
The goal of this prospective observational study is to identify the common pathogens and antibiotic sensitivity pattern in urine samples of men with symptomatic BPH and to assess severity of LUTS in patients with symptomatic BPH using IPSS score before and after antibiotic therapy.
Conditions
- Bacteriuria in Symptomatic Benign Prostate Hyperplasia
- Antibiotic Susceptibility in Symptomatic Benign Prostate Hyperplasia
- Treatment Response to Antibiotics in Symptomatic Benign Prostate Hyperplasia
Interventions
- DRUG
-
Antibiotic therapy
Urine culture and antibiotic sensitivity tests were conducted to assess the bacteriological profile. The patients were then prescribed antibiotics based on susceptibility testing for a duration of 1 week.
Sponsors & Collaborators
-
Tribhuvan University Teaching Hospital, Institute Of Medicine.
lead OTHER
Eligibility
- Min Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2021-06-12
- Completion
- 2021-08-15
Countries
- Nepal
Study Locations
More Related Trials
-
Ultrasound IPP to Predict Response to Medical Therapy in LUTS/BPH
NCT07306767 ·Status: COMPLETED
-
Impact of TURP on Quality of Life in Patients With Benign Prostatic Hyperplasia: A Retrospective Study
NCT06995963 ·Status: COMPLETED
-
Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH
NCT03179670 ·Status: COMPLETED
-
Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients with BPH.
NCT05401032 ·Status: RECRUITING ·Phase: PHASE2
-
Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1
NCT01661621 ·Status: COMPLETED ·Phase: PHASE4
-
Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)
NCT00670306 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Median Lobe Prostatic UroLift Procedure
NCT02625545 ·Status: COMPLETED ·Phase: NA
-
Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia
NCT02313233 ·Status: COMPLETED ·Phase: NA
-
The Changes of Urine Growth Factors Level
NCT06282731 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
NCT00663858 ·Status: COMPLETED ·Phase: PHASE3
-
Identification and Treatment of Men With BPH in the Primary Care Setting
NCT00211640 ·Status: COMPLETED
-
BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia
NCT01533038 ·Status: COMPLETED ·Phase: NA
-
Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration
NCT02041767 ·Status: COMPLETED ·Phase: PHASE4
-
Protocollo N 2014 - Benign Prostatic Hyperplasia
NCT06182189 ·Status: RECRUITING
-
Treatment of Chronic Bacterial Prostatitis
NCT02130713 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)
NCT00651807 ·Status: TERMINATED ·Phase: PHASE2
-
Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients
NCT06016595 ·Status: COMPLETED
-
Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH
NCT01966614 ·Status: COMPLETED ·Phase: PHASE3
-
A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy
NCT01275521 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effects of a Prostate Health Formulation
NCT02886832 ·Status: COMPLETED ·Phase: NA
-
Antibiotic Prophylaxis for Transrectal Prostate Biopsy
NCT01659866 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL
NCT01351987 ·Status: UNKNOWN
-
Retrospective Chart Review of Treataprost Added to Antibiotic Treatment in Patients With Chronic Prostatitis
NCT05306314 ·Status: UNKNOWN
-
Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy
NCT01566292 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)
NCT02656173 ·Status: COMPLETED ·Phase: PHASE4